P. Hanjani

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.

Stephen Williams, J A Blessing, S Y Liao et al. · Journal of Clinical Oncology · 1994 · 341 citations

Telephone counseling improves adherence to colposcopy among lower-income minority women.

Caryn Lerman, P. Hanjani, C Caputo et al. · Journal of Clinical Oncology · 1992 · 182 citations

Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.

Maurie Markman, Mark F. Brady, Nick M. Spirtos et al. · Journal of Clinical Oncology · 1998 · 141 citations

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

Bradley J. Monk, Mark F. Brady, Carol Aghajanian et al. · Annals of Oncology · 2017 · 89 citations · Full text

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

Irene Braña, Raanan Berger, Talia Golan et al. · British Journal of Cancer · 2014 · 88 citations · Full text